Mitochondrial Health
Definition and Overview
Mitochondria are organelles â structures within cells that perform specific functions. Scientists often call mitochondria the powerhouses of the cell, because they produce about 90% of the energy that cells need to function. They are semi-autonomous organelles present in all eukaryotic cells except for adult mammalian red blood cells. Typically, mitochondria have an elliptical or rod-shaped structure and are enveloped by two membranes: an inner membrane and an outer membrane. The cristae, which have intricate folding patterns on the inner membrane, enhance the available surface area for efficient oxidative phosphorylation.
Aside from producing the majority of ATP through oxidative phosphorylation, which provides essential energy for cellular functions, mitochondria also participate in other metabolic processes within the cell, such as the electron transport chain, citric acid cycle, and ÎČ-oxidation of fatty acids. Furthermore, mitochondria regulate the production and elimination of ROS, the synthesis of nucleotides and amino acids, the balance of calcium ions, and the process of cell death.
Their function is not limited to energy production but serves multiple mechanisms varying from iron and calcium homeostasis to the production of hormones and neurotransmitters, such as melatonin. They enable and influence communication at all physical levels through interaction with other organelles, the nucleus, and the outside environment. The literature suggests crosstalk mechanisms between mitochondria and circadian clocks, the gut microbiota, and the immune system.
NAD+ is a cofactor for NAD+-dependent protein lysine deacetylases that regulate various cellular functions, including nutrient sensing, energy metabolism, and stress responses. Mitochondria are the main regulators of cellular and systemic NAD+/NADH ratio, and through this function, mitochondrial status broadly influences cell and organismal health.
There is a direct correlation between the energy demands of cells and the amount of mitochondria they contain. Muscle (especially heart muscle), brain, and liver cells are the most active, energy-demanding cells of the body, and can have several thousand mitochondria per cell.
Mitochondrial Dysfunction: Definition and Presentation
Mitochondrial dysfunction can be the primary cause or a secondary effect of many human disorders, including neurodegenerative diseases, obesity, and cancer. However, mitochondrial diseases specifically refer to a group of heterogeneous disorders characterized by impaired oxidative phosphorylation, the process by which cells transform nutrient-derived energy into ATP.
Hallmarks of mitochondrial dysfunction include decreased ATP production, decreased mitochondrial membrane potential, swollen mitochondria, damaged cristae, increased oxidative stress, and decreased mitochondrial DNA copy number.
Mitochondrial dysfunction induces an imbalance between oxidation and antioxidation, mitochondrial DNA (mtDNA) damage, mitochondrial dynamics dysregulation, and changes in mitophagy. It results in oxidative stress due to excessive reactive oxygen species (ROS) generation, which contributes to cell damage and death. Mitochondrial dysfunction can also trigger inflammation through the activation of damage-associated molecular patterns (DAMPs), inflammasomes, and inflammatory cells.
Mitochondrial disorders almost always cause progressive damage to the muscles and, often, the nervous system. "These are among the body's most energy-hungry cells," says Dr. Brian Glancy, an NIH researcher who studies mitochondria in muscle. When mitochondria cannot supply this energy in inherited mitochondrial disorders, problems can range from muscle fatigue and weakness to vision and hearing loss and even paralysis and death.
Body Systems Involved
Cardiovascular System
Changes in mitochondrial function contribute to the pathogenesis of atherosclerosis, hypertension, and diabetes by promoting endothelial apoptosis and impairing cellular energy metabolism. Mitochondrial dysfunction is a key feature of chronic heart failure, leading to a maladaptive bioenergetic response and a progressive reduction in energy reserves, irrespective of the underlying cause.
Nervous System
Research has highlighted the centrality of mitochondrial dysfunction in brain aging, where it drives chronic inflammation, oxidative stress, and excitotoxicity. These factors collectively degrade neural networks, and disruptions in mitochondrial function lead to a decline in the efficiency of neural communication. This diminished clarity in neural signaling contributes to the development and progression of neurodegenerative diseases.
Liver and Metabolic Organs
The liver is another organ profoundly affected by mitochondrial impairment. Mitochondrial dysfunction plays a pivotal role in non-alcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma.
Skeletal Muscle
Skeletal muscle comprises the largest organ in the body and is the largest contributor to aerobic capacity through mitochondrial respiration. Hence, skeletal muscle mitochondrial function is crucial for whole-body metabolic function and health.
Immune System
Increasingly, the role of mitochondria in innate immunity has been studied. Aging produces three main effects on this system: inflammation with aging, susceptibility to viral infections, and declining T-cell function. Mitochondrial damage-associated molecular patterns (mtDAMPs), when released from mitochondria as a consequence of stress, apoptosis, or necrosis, trigger caspase-1 activation with the release of pro-inflammatory cytokines.
Contributing and Associated Factors
Aging
Mitochondrial dysfunction has been reported to be associated with aging and almost all chronic aging-associated diseases through reduced ATP production. As aging progresses, NAD+ levels in human cells decrease, causing a breakdown in communication between the human nucleus and mitochondrial DNA, again leading to decreased energy production and increased ROS production. The cellular senescence driven via various factors of mitochondrial dysfunction has been collectively termed mitochondrial dysfunction-associated senescence (MiDAS). Cells undergoing MiDAS are characterized by lower NAD+/NADH ratios, leading to cell growth arrest and IL-1-associated senescence-associated secretory phenotype (SASP).
Genetic Factors
Impairment of the mitochondria may be caused by mutations or deletions in nuclear or mitochondrial DNA (mtDNA). Mitochondrial diseases have been recognized as pathway-based diseases rather than merely energy-deficit diseases. The variable clinical presentations and tissue specificity suggest that there are contributing factors beyond energy deficit during disease development. Furthermore, genetic defects are not always sufficient to cause cellular dysfunction as mitochondria can buffer against mitochondrial lesions, making environmental insults sometimes important to trigger these genetic disorders.
Metabolic and Dietary Factors
The oxidation of multiple fuels occurs within the matrix of mitochondria through the TCA cycle and OXPHOS. Mitochondria oxidize all major substrates derived from macronutrients: pyruvate derived from carbohydrates, fatty acids derived from fat, and amino acids derived from protein. Other metabolites, such as ketone bodies, are also commonly oxidized by mitochondria, especially under stress and fasting conditions. Chronic overnutrition, excess saturated fat intake, and metabolic syndrome are associated with impaired mitochondrial bioenergetics through mechanisms including lipotoxicity and insulin resistance.
Oxidative Stress and Inflammation
Mitochondrial alterations in functional regulation, energy metabolism, and genetic stability accompany the aging process, and there is a lot of evidence suggesting that oxidative stress and inflammation, both of which are associated with mitochondrial dysfunction, are predisposing factors of aging. In neurodegenerative diseases, mitochondrial dysfunction impairs ATP production and promotes the generation of reactive oxygen species (ROS). The accumulation of ROS further damages mitochondrial DNA, proteins, and lipids, creating a vicious cycle of oxidative stress and mitochondrial impairment.
Environmental Toxins and Pollutants
Environmental factors including diet, sedentary lifestyle, and exposure to pollutants largely influence human health throughout life. Cellular and molecular events triggered by an exposure to environmental pollutants are extremely variable and depend on the age, the chronicity, and the doses of exposure. Mitochondria are central hubs of metabolic and cell signaling responsible for a large variety of biochemical processes, including oxidative stress, metabolite production, energy transduction, hormone synthesis, and apoptosis. Growing evidence highlights mitochondrial dysfunction as a major hallmark of environmental insults.
Sleep Disruption
Insufficient sleep gradually elevates oxidative stress and impairs mitochondrial function. Both oxidative stress and mitochondrial dysfunction are critical factors in the pathology of neurodegenerative disorders. Prolonged sleep deprivation ultimately leads to an imbalance of normal cellular processes and an overproduction of reactive oxygen species. These detrimental compounds can damage fat molecules, proteins, and even DNA, and, as a result, intracellular mitochondria become dysfunctional, leading to reduced ATP production and further compromising the energy supply. The brain requires a specialised form of mitochondrial quality control called mitophagy. Mitophagy is less efficient in older individuals or those with chronic sleep deprivation. The accumulation of unprocessed mitochondria exacerbates oxidative stress while further depleting energy-storing substrates.
Sedentary Behaviour
Chronic sleep loss, metabolic dysfunction, environmental toxins, stress, and physical inactivity elevate systemic inflammation and ROS-mediated cellular damage. It has been known for decades that physical activity is probably the only known intervention that can improve mitochondrial function.
Nutrients, Herbs, and Natural Ingredients
Coenzyme Q10 (CoQ10 / Ubiquinone)
Biological Role
Coenzyme Q10 (CoQ10) is a vitamin-like organic compound widely expressed in humans as ubiquinol (reduced form) and ubiquinone (oxidized form). CoQ10 plays a key role in electron transport in oxidative phosphorylation of mitochondria. CoQ10 acts as a potent antioxidant, membrane stabilizer, and cofactor in the production of adenosine triphosphate by oxidative phosphorylation, inhibiting the oxidation of proteins and DNA.
Traditional Use
CoQ10 was first isolated in 1957 and its role in the mitochondrial electron transport chain was elucidated through biochemical research rather than traditional herbal medicine systems. By 1974, the Japanese government had approved CoQ10 for treating congestive heart failure, demonstrating its early therapeutic adoption. It has no established pre-modern traditional use as an isolated compound.
Scientific Evidence
Case reports and open-label studies suggest that CoQ10 treatment may have beneficial effects in mitochondrial disease patients; however, controlled trials are warranted to clinically prove its effectiveness. Thirty patients with mitochondrial cytopathy received 1,200 mg/day CoQ10 for 60 days in a randomized, double-blind, cross-over trial. CoQ10 treatment attenuated the rise in lactate after cycle ergometry, increased VO2/kg lean mass after five minutes of cycling, and decreased gray matter choline-containing compounds. However, sixty days of moderate- to high-dose CoQ10 treatment had minor effects on cycle exercise aerobic capacity and post-exercise lactate and did not affect other clinically relevant outcomes.
Compared with the placebo group, the effect of reducing fatigue was statistically significant in the subgroup using the CoQ10-only formulation but not in the subgroup using CoQ10 compounds. Meta-regression demonstrated that increases in the daily dose and treatment duration of CoQ10 supplementation were correlated with greater fatigue reduction.
Patients with heart failure showed CoQ10 deficiency; therefore, a number of clinical trials investigating the effects of CoQ10 supplementation in heart failure have been conducted. CoQ10 supplementation may confer potential prognostic advantages in heart failure patients with no adverse hemodynamic profile or safety issues. Since the late 1980s, randomized controlled trials (RCTs) investigating CoQ10 in heart failure patients have been conducted. While these trials have shown promise, many have been too underpowered to significantly address clinical outcomes, leaving gaps in the evidence.
Fibromyalgia patients have depleted CoQ10 levels in tissues (typically 40â50% of the normal level), together with increased levels of mitochondrial dysfunction, oxidative stress, and inflammation, both in adults and in children/adolescents. However, a randomised controlled trial supplementing CoQ10 (500 mg/day for 6 weeks) found no significant benefit on reducing the number or severity of symptoms in patients with post-COVID-19 condition.
Evidence strength: Moderate, primarily for heart failure and fatigue. Positive signals exist from clinical trials, but many are underpowered. Evidence for broader mitochondrial disease contexts remains preliminary.
B Vitamins (Thiamine, Riboflavin, Niacin, Pantothenic Acid)
Biological Role
B vitamins are involved at nearly every step of mitochondrial energy production. B1 (thiamine) helps convert pyruvate into acetyl-CoA, the molecule that enters the Krebs cycle; without it, glucose essentially cannot be turned into usable energy. B2 (riboflavin) forms the electron carriers FAD and FMN, which serve as cofactors at complexes I and II of the electron transport chain, and is also required for two reactions within the Krebs cycle. B3 (niacin) is the precursor to NAD and NADH, the primary electron carriers that feed into complex I of the electron transport chain.
Traditional Use
B vitamins are not derived from a single herbal tradition. Thiamine deficiency (beriberi) was recognized empirically in East Asian populations consuming polished rice, and whole-grain foods were used traditionally as a corrective long before the biochemical mechanism was identified. Niacin deficiency (pellagra) was recognised historically in populations with maize-dominant diets; traditional preparations such as nixtamalization in Mesoamerica improved niacin bioavailability from maize. These practices reflect nutritional observations rather than targeted mitochondrial therapy.
Scientific Evidence
Thiamine functions as a cofactor for the pyruvate dehydrogenase complex (PDHC), the critical enzyme linking glycolysis to the Krebs cycle. Thiamine (Vitamin B1) is a cofactor of alpha-ketoacid dehydrogenases, including the pyruvate dehydrogenase complex. Riboflavin supplementation has demonstrated clinical benefit in riboflavin-responsive mitochondrial complex I deficiency, a rare but well-documented mitochondrial disorder. CoQ10 and selenium together have important roles in the normal function of the heart, and clinical trials supplementing CoQ10 and selenium have shown significant benefit in reducing the risk of developing heart disease in normal individuals as well as reducing mortality risk in heart failure patients. In the context of primary mitochondrial disease, the Mitochondrial Medicine Society guidelines have considered B vitamin cofactors as foundational therapeutic agents.
Evidence strength: Strong for deficiency correction; well-established at the biochemical level. Clinical trial data for healthy populations supplementing above dietary reference levels is limited.
NAD+ Precursors: Nicotinamide Riboside (NR) and Nicotinamide Mononucleotide (NMN)
Biological Role
NAD+ is a cofactor for the NAD+-dependent protein lysine deacetylases that regulate various cellular functions, including nutrient sensing, energy metabolism, and stress responses. Mitochondria are the main regulators of cellular and systemic NAD+/NADH ratio, and through this function, mitochondrial status broadly influences cell and organismal health. As aging progresses, NAD+ levels in human cells decrease, causing a breakdown in communication between the human nucleus and mitochondrial DNA, again leading to decreased energy production and increased ROS production.
Traditional Use
NR and NMN are novel compounds without pre-modern traditional use. Niacin (vitamin B3), a related NAD+ precursor, has a long history of use in clinical nutrition since the mid-twentieth century for lipid management, but its role as a mitochondrial NAD+ replenisher is a contemporary research focus.
Scientific Evidence
A 2023 study found that nicotinamide riboside (NR) supplementation increased systemic NAD+, enhanced muscle mitochondrial biogenesis, increased mitochondrial DNA, and enhanced mitochondrial metabolism and stem cell function. Human clinical trials have confirmed that NR and NMN supplementation can effectively raise blood and tissue NAD+ levels, though evidence for downstream functional or clinical benefits beyond biomarker changes remains developing. Human data focusing on the impact of resveratrol on mitochondrial function are scarce, with a limited number of subjects involved â a caveat that applies broadly to NAD+ precursor research in humans. The evidence in humans is still developing, but the biological rationale is strong. NAD+ is so fundamental to energy production that restoring depleted levels, particularly in older adults, has a plausible path to meaningful benefit.
Evidence strength: Preliminary to moderate. Biomarker evidence (rising NAD+ levels) is consistent; clinical outcome data is limited, and large trials are ongoing.
Alpha-Lipoic Acid (ALA)
Biological Role
Alpha-lipoic acid functions as a cofactor for two key mitochondrial enzyme complexes â pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase â that are essential to the Krebs cycle. It also regenerates other antioxidants, including vitamin E and glutathione, which protect mitochondrial membranes from the oxidative byproducts of energy production. What sets ALA apart from other antioxidants is that it crosses the blood-brain barrier, providing mitochondrial support in neurons â cells that are particularly energy-intensive and vulnerable to mitochondrial decline.
Traditional Use
ALA as an isolated compound has no pre-modern traditional use. It was first identified in 1951 by biochemists at the University of Texas as a growth factor for Lactobacillus casei. Its recognition as an endogenous mitochondrial cofactor and therapeutic antioxidant is entirely a product of modern biochemistry and pharmacology, particularly from German research in the latter half of the twentieth century, where it gained approval for the treatment of diabetic neuropathy.
Scientific Evidence
Studies have shown that alpha-lipoic acid supplementation can improve mitochondrial function and reduce oxidative damage markers in patients with mitochondrial disorders. A study in the Orphanet Journal of Rare Diseases found that a combination of CoQ10, creatine, and lipoic acid improved several clinical parameters in patients with mitochondrial disorders by addressing multiple aspects of cellular health simultaneously. Clinical trials in diabetic neuropathy have produced the most robust human evidence; evidence specifically for mitochondrial disease treatment is largely from small or open-label studies.
Evidence strength: Moderate for diabetic neuropathy (consistent clinical trial data); preliminary for broader mitochondrial disease populations.
L-Carnitine and Acetyl-L-Carnitine (ALCAR)
Biological Role
Long-chain fatty acids first bind to CoA to form fatty acyl CoA, which in turn binds with L-carnitine, and the resulting acylcarnitine is shuttled through the inner membrane and into the mitochondria. The acylcarnitine undergoes the reverse process in the matrix, liberating the fatty acyl CoA for subsequent ÎČ-oxidation. The breakdown of the fatty acid molecule by ÎČ-oxidation into smaller two-carbon molecules permits their entry into the Krebs cycle and subsequent production of ATP.
Traditional Use
L-carnitine is not derived from traditional herbal medicine. L-carnitine in humans is both endogenously synthesized and obtained through food ingestion and is also used as a drug. Red meat is the primary dietary source. Its role in fatty acid metabolism was characterised through mid-twentieth-century biochemistry, and clinical use developed primarily in the context of inborn errors of fatty acid oxidation and renal dialysis-associated deficiency.
Scientific Evidence
There is compelling evidence from preclinical studies that L-carnitine and ALCAR can improve energy status, decrease oxidative stress, and prevent subsequent cell death in models of adult, neonatal, and pediatric brain injury. A meta-analysis of four randomized, placebo-controlled trials found evidence of a reduction in fasting plasma glucose concentration and no improvement of glycated hemoglobin concentration in subjects with type 2 diabetes mellitus supplemented with acetyl-L-carnitine (ALCAR).
Regarding cardiovascular risk, the picture is mixed: L-carnitine, a ubiquitous nutritional supplement, has been investigated as a potential therapy for cardiovascular disease. Clinical studies suggest improvement of some cardiovascular risk factors, whereas others show increased plasma levels of pro-atherogenic trimethylamine N-oxide (TMAO). The Mitochondrial Medicine Society has noted that clinical data has suggested L-carnitine may accelerate atherosclerotic disease in some populations, reflecting an important caveat in the literature.
Evidence strength: Strong for primary carnitine deficiency and inborn errors of fatty acid oxidation. Mixed for broader metabolic and cardiovascular contexts. The TMAO concern warrants ongoing evaluation.
Magnesium
Biological Role
Magnesium is required for the activity of all enzymes that use and many that synthesize ATP. Importantly, ATP itself must bind to a magnesium ion to be biologically active. Consequently, magnesium availability is paramount for the efficiency of mitochondrial cell energy generation and for the viability of all cellular activities that require ATP.
Traditional Use
Magnesium-rich foods (legumes, leafy greens, nuts, seeds) have been staples across diverse traditional dietary systems, though magnesium was not conceptually isolated as a mitochondrial cofactor in pre-modern frameworks. Epsom salt (magnesium sulfate) baths have a folk tradition in Western natural medicine for fatigue and muscle soreness, predating any formal understanding of cellular energy metabolism.
Scientific Evidence
Magnesium deficiency is common in modern populations and has been associated with impaired glucose metabolism and increased oxidative stress. Clinical trials in diabetes, hypertension, and muscle function support the importance of adequate magnesium status. However, high-quality clinical trials specifically framing magnesium as a "mitochondrial support" supplement in non-deficient populations are limited. The evidence base is strongest for correcting deficiency.
Evidence strength: Strong for deficiency correction and specific conditions (metabolic syndrome, cardiovascular risk); limited for supplementation above adequate intake levels in mitochondrial disease specifically.
Resveratrol
Biological Role
Resveratrol seems an exquisite candidate for mitochondrial dysfunction, as the compound has been observed to possess mitogenetic, antioxidant, and anti-apoptotic activities. Resveratrol upregulates mitochondrial antioxidative enzymes and triggers mitochondrial biosynthesis, thus acting as a mitochondrial protective substance.
Traditional Use
Resveratrol, a natural polyphenol contained in blueberry, grapes, mulberry, and others, is well documented to exhibit potent neuroprotective activity against different neurodegenerative diseases by a mitochondria modulation approach. Grapes and mulberry have long histories of use in traditional Chinese medicine (TCM) â Vitis vinifera root and Morus alba appear in classical TCM texts â and red wine has been part of Mediterranean culinary traditions. However, resveratrol as an isolated compound was not identified until 1940, and its specific association with mitochondrial pathways is entirely modern.
Scientific Evidence
Unfortunately, human data focusing on the impact of resveratrol on mitochondrial function are scarce, with a limited number of subjects involved. Preclinical data in cell and animal models are more robust, demonstrating activation of SIRT1/PGC-1α pathways that govern mitochondrial biogenesis. Resveratrol is a signaling polyphenol linked to pathways like SIRT1/PGC-1α that govern mitochondrial adaptation. Its use increases mitochondrial mass and biogenesis markers in human cells and supportive animal findings, but real-world effects depend heavily on dose, bioavailability, and the person's baseline state.
Evidence strength: Preliminary in humans. Animal and in vitro evidence is suggestive; bioavailability challenges limit translation to clinical benefit.
Pyrroloquinoline Quinone (PQQ)
Biological Role
PQQ is described as a signal that may encourage the body to make or maintain healthier mitochondria (biogenesis) and support antioxidant defenses. Instead of just pushing mitochondria to make more energy, it is described as improving mitochondrial quality control, including mitophagy, the cellular process that identifies and clears out damaged mitochondria so the healthy ones can do their job.
Traditional Use
PQQ is a redox cofactor found in trace amounts in soil and in fermented foods, certain vegetables, and human breast milk, but was only discovered in 1979 and characterised as relevant to mitochondrial biogenesis in the early 2000s. It has no traditional use as an isolated supplement.
Scientific Evidence
PQQ supplementation is associated with lower inflammatory markers like C-reactive protein. Mechanistically, PQQ also links into NAD+ production. Human clinical trials with PQQ are limited in number and size. Most data supporting mitochondrial biogenesis effects come from cell-based and rodent studies. A small number of human trials have examined cognitive outcomes and inflammatory markers with mixed results. Evidence is preliminary and requires larger, well-designed trials.
Evidence strength: Preliminary. Mechanistic rationale is plausible but human clinical data are sparse.
Berberine
Traditional Use
Berberine is an active natural component of the traditional Chinese herb Coptidis Rhizoma. In traditional Chinese and Ayurvedic medicine, berberine-containing plants such as Coptis chinensis (goldthread), Berberis vulgaris (barberry), and Hydrastis canadensis (goldenseal) have been used for thousands of years primarily as antimicrobial and digestive agents, and for treatment of diarrhea, inflammation, and infections. Their mitochondrial effects were not part of the original therapeutic framework.
Scientific Evidence
Berberine has been shown in experimental models to protect against high-fat-diet-induced dysfunction in muscle mitochondria by inducing SIRT1-dependent mitochondrial biogenesis. The natural compound berberine has been reported to exhibit anti-diabetic activity and to improve disordered lipid metabolism. Such compounds upregulate expression of sirtuin 1 â a key molecule in caloric restriction â making it of great interest to examine lipid-lowering activity in combination with a sirtuin 1 activator like resveratrol. Human clinical evidence for berberine is most robust in the areas of blood glucose management and lipid reduction; direct human evidence for mitochondrial biogenesis effects specifically remains limited, with most supporting data coming from animal models.
Evidence strength: Moderate for metabolic and lipid outcomes in humans; preliminary for mitochondria-specific endpoints.
Dietary and Lifestyle Factors
Physical Exercise
It has been known for decades that physical activity is probably the only known intervention that can improve mitochondrial function. The "exercise as medicine" concept continues to grow among health professionals as a necessity to prescribe exercise in a personalized and individualized manner.
Among the many molecular and cellular adaptations that occur in response to aerobic exercise training are increased mitochondrial biogenesis and enhanced potential for oxidative metabolism. Mitochondrial biogenesis is transcriptionally controlled through the activation of peroxisome proliferator-activated receptor-gamma coactivator 1α (PGC-1α). PGC-1α can be activated by reduced ATP/AMP levels mediated by AMP-activated protein kinase (AMPK) that functions as a cellular energy sensor. Both endurance and high-intensity interval training have been studied for their capacity to stimulate PGC-1α-driven mitochondrial biogenesis.
Caloric Restriction
Calorie restriction (CR) is the only environmental intervention known to extend lifespan and delay aging in species ranging from yeast to humans. Molecularly, CR provides many benefits, including sensitized insulin signaling, strengthened stress response pathways, and improved mitochondrial functions. The beneficial effects of CR on mitochondrial functions are well established, and several studies suggest that CR stimulates mitochondrial biogenesis.
Combining caloric restriction and endurance exercise can improve mitochondrial biogenesis within the skeletal muscles of rats fed with a high-fat diet. In addition to potentially affecting PGC-1α expression, these effects were consistent with the amelioration of insulin resistance. These findings are largely from animal models; the translation to practical human dietary guidance remains an active area of research.
Dietary Pattern and Macronutrient Composition
The oxidation of multiple fuels occurs within the matrix of mitochondria through the TCA cycle and OXPHOS. Mitochondria oxidize all major substrates derived from macronutrients: pyruvate derived from carbohydrates, fatty acids derived from fat, and amino acids derived from protein. Dietary patterns that reduce chronic overnutrition, minimize processed foods, and emphasize micronutrient density are discussed in the literature as supportive of mitochondrial function. High-fat, Western-style diets have been associated with increased mitochondrial ROS production and impaired metabolic flexibility in both animal and human studies.
Pathological aging is exacerbated by various factors, including sleep disruption, metabolic disorders such as obesity and diabetes, and adverse lifestyle behaviors such as alcohol consumption, smoking, and diets high in processed foods.
Sleep
Mitochondrial dysfunction can cause disruptions in the circadian system by impairing the energy production needed to regulate circadian clocks and sleep homeostasis. Alterations in ATP production can reduce the function of adenosine, a molecule that promotes sleep. Additionally, changes in mitochondrial metabolism can affect melatonin synthesis, a hormone critical for sleep regulation. Dysfunctional mitochondria can also lead to increased production of ROS, further damaging cells and disrupting circadian rhythm synchronization. These factors can collectively contribute to various sleep disorders, including insomnia, sleep apnea, and circadian rhythm sleep-wake disorders.
Sleep and exercise engage overlapping signaling pathways that regulate mitochondrial biogenesis, redox-sensitive gene expression, and neuroinflammation.
Stress and Psychological Factors
Chronic psychological stress activates the hypothalamic-pituitary-adrenal (HPA) axis and sympathetic nervous system, driving sustained glucocorticoid release that has been associated in experimental research with mitochondrial dysfunction, reduced mitochondrial membrane potential, and increased ROS generation. Mitochondria serve as central hubs regulating oxidative stress, inflammation, and aging, and their dysfunction contributes to various diseases, including cancers, cardiovascular diseases, neurodegenerative disorders, metabolic diseases, sepsis, ocular pathologies, liver diseases, and autoimmune conditions.
Environmental Toxin Avoidance
Growing evidence highlights mitochondrial dysfunction as a major hallmark of environmental insults. Mitochondria are crucial organelles for healthy metabolic homeostasis and their dysfunction induces critical adverse effects. Specific classes of environmental pollutants implicated in the literature include heavy metals (arsenic, cadmium, lead, mercury), organophosphate pesticides, polycyclic aromatic hydrocarbons, and, more recently, microplastics. Oxidative stress, inflammatory responses, mitochondrial dysfunction, and iron metabolism disorders are key roles in microplastic-induced neurotoxicity, with significant interconnections among these mechanisms.
Summary of Evidence Levels
- CoQ10: Moderate human clinical evidence for heart failure and fatigue reduction; preliminary for broader mitochondrial disease. Several RCTs conducted but many underpowered.
- B Vitamins (B1, B2, B3, B5): Strong biochemical and clinical evidence for deficiency correction; essential cofactors at characterized enzymatic steps. Evidence for supplementation in non-deficient populations is limited.
- NAD+ precursors (NR, NMN): Biomarker evidence is consistent (raised NAD+); functional and clinical outcome evidence in humans is preliminary. Ongoing trials warranted.
- Alpha-Lipoic Acid: Moderate for diabetic neuropathy; preliminary for primary mitochondrial disease. Most supporting evidence from preclinical models.
- L-Carnitine / ALCAR: Strong for primary deficiency; mixed for broader metabolic disease; TMAO concern in cardiovascular populations warrants caution.
- Magnesium: Strong for deficiency correction; biochemical rationale for ATP function is solid; direct clinical evidence for mitochondrial disease supplementation is limited.
- Resveratrol: Preliminary in humans; robust in vitro and animal data; bioavailability challenges limit translation.
- PQQ: Preliminary; mechanistically plausible but limited human trials.
- Berberine: Moderate for metabolic and lipid outcomes; preliminary for mitochondria-specific endpoints in humans.
- Exercise: Strong; the most consistently documented lifestyle intervention for improving mitochondrial function.
- Caloric restriction: Well-established in animal models for mitochondrial biogenesis; human data are encouraging but more limited.
References
Go back